How will the Clinicians, Patients and Consumers of the Future ensure appropriate use of brain enhancement methods encompassing lifestyle, supplements, brain training, meditation, bio/ neurofeedback, tDCS and more?
*Dr. Eddie Martucci, Co-Founder and CEO of Akili Interactive Labs
*Dr. Anna Wexler, science writer, filmmaker and postdoc fellow at the Department of Medical Ethics and Health Policy at UPenn’s Perelman School of Medicine
*Dr. Olivier Oullier, President of EMOTIV
*Dr. Peter Reiner, Co-Founder of the National Core for Neuroethics at the University of British Columbia
*Chaired by: Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization (NIO)
*Álvaro Fernández, CEO and Editor-in-Chief of SharpBrains
*Sarah Lenz Lock, Senior Vice President for Policy at AARP and Executive Director of the Global Council on Brain Health (GCBH)
*Dr. April Benasich, Director of the Baby Lab at the Rutgers Center for Molecular and Behavioral Neuroscience
*Chaired by: Dr. Cori Lathan, Co-Chair of the World Economic Forum’s Council on the Future of Human Enhancement
Slidedeck supporting session held during the 2017 SharpBrains Virtual Summit: Brain Health & Enhancement in the Digital Age (December 5-7th). Learn more at: https://sharpbrains.com/summit-2017/
How can practitioners integrate emerging neuroplasticity-based interven...
Similar to How will the Clinicians, Patients and Consumers of the Future ensure appropriate use of brain enhancement methods encompassing lifestyle, supplements, brain training, meditation, bio/ neurofeedback, tDCS and more?
Similar to How will the Clinicians, Patients and Consumers of the Future ensure appropriate use of brain enhancement methods encompassing lifestyle, supplements, brain training, meditation, bio/ neurofeedback, tDCS and more? (20)
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
How will the Clinicians, Patients and Consumers of the Future ensure appropriate use of brain enhancement methods encompassing lifestyle, supplements, brain training, meditation, bio/ neurofeedback, tDCS and more?
1.
2.
3. How will the Clinicians, Patients and Consumers of the Future ensure
appropriate use of brain enhancement methods encompassing lifestyle,
supplements, brain training, meditation, bio/ neurofeedback, tDCS and
more?
Dr. Anna Wexler, science
writer, filmmaker and
postdoc fellow at the
Department of Medical
Ethics and Health Policy
at UPenn’s Perelman School
of Medicine
Dr. Eddie Martucci, Co-
Founder and CEO of Akili
Interactive Labs
Dr. Olivier Oullier, President
of EMOTIV
Dr. Peter Reiner, Co-Founder
of the National Core for
Neuroethics at the
University of British
Columbia
Chaired by: Dr. Alison
Fenney, Executive Director
of the Neurotechnology
Industry Organization
(NIO)
4. Yesterday in the news…
Dr. Eddie Martucci
CEO of Akili
Interactive Labs
5. The future of tDCS: ensuring appropriate use by clinicians, patients and
consumers of the future
Anthony Lee; Photo credit, David Yellen (IEEE Spectrum, 3/14/14)
Anna Wexler
SharpBrains Virtual Summit | December 5, 2017
Post-doctoral fellow, Department of Medical Ethics & Health Policy
Perelman School of Medicine, University of Pennsylvania
12. tDCS in the clinic
Administration/prescription of drugs is relatively well regulated in the US, but
administration/use of medical devices (i.e., those providing brain stimulation) is not
13. Researchers
Medical
practitioners/therapists
Consumers/home
users
Use tDCS in the laboratory
Apply tDCS to subjects
Primary purpose: research
Controlled/regulated
environment
Use tDCS at home
Apply tDCS to themselves
Primary purpose: self-
improvement
Uncontrolled environment
Use tDCS in the clinic
Apply tDCS to clients/patients
Primary purpose: clinical
treatment
Semi-controlled environment
14. Researchers
Medical
practitioners/therapists
Consumers/home
users
Use tDCS in the laboratory
Apply tDCS to subjects
Primary purpose: research
Controlled/regulated
environment
Use tDCS at home
Apply tDCS to themselves
Primary purpose: self-
improvement
Uncontrolled environment
Use tDCS in the clinic
Apply tDCS to clients/patients
Primary purpose: clinical
treatment
Semi-controlled environment
How can we ensure appropriate use across these three domains?
15. Post-doctoral fellow, Department of
Medical Ethics & Health Policy
Perelman School of Medicine, University of
Pennsylvania
Anna Wexler
Thank you!
awex@upenn.edu